✦ LIBER ✦

Immunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humans

✍ Scribed by Timothy J. Eberlein; Mary L. Rodrick; Anthony F. Massaro; Sung-Eun Jung; John A. Mannick; Deric D. Schoof

Publisher: Springer-Verlag
Year: 1989
Tongue: English
Weight: 799 KB
Volume: 30
Category: Article
ISSN: 0340-7004
DOI: 10.1007/bf01669422

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Continuous infusion of recombinant inter

Continuous infusion of recombinant interleukin-2 and lymphokine-activated killer cells in refractory malignancies

✍ Christiansen, Neal P. ;Kennedy, B. J. ;Ochoa, Augusto C. ;Skubitz, Keith M. ;Bac 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB

Induction of lymphokine-activated killer

Induction of lymphokine-activated killer cells from rat thymocytes using recombinant human interleukin-2

✍ Hisatoshi Imaya; Hiroshi Matsuura; Motoshige Kudo; Shozo Nakazawa 📂 Article 📅 1988 🏛 Springer-Verlag 🌐 English ⚖ 405 KB

Using a 4-h 51Cr release assay, we observed that thymocytes from Fischer strain rats incubated with recombinant human interleukin-2 (rhIL-2) developed cytotoxicity to YAC-1 lymphoma, 9L-glioma, and B-16 melanoma cells (effector/target ratio = 25/1). Induction of the lymphokine-activated killer (LAK)

Potentiated lymphokine-activated killer

Potentiated lymphokine-activated killer cell activity generated by low-dose interleukin-2 and mismatched double-stranded RNA

✍ Howard R. Hubbell; George D. Gibson; Robert D. Bigler 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 782 KB

Interaction of recombinant interferons w

Interaction of recombinant interferons with recombinant interleukin-2: Differential effects on natural killer cell activity and interleukin-2-activated killer cells

✍ Michael J. Brunda; Deborah Tarnowski; Viveca Davatelis 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 French ⚖ 701 KB

The augmentation of lymphokine-activated

The augmentation of lymphokine-activated killer activity following pulsing of human peripheral blood mononuclear cells with recombinant human interleukin-2

✍ C. R. D. Carter; B. W. Hancock; R. C. Rees 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 925 KB

Adoptive immunotherapy with lymphokine-a

Adoptive immunotherapy with lymphokine-activated killer cells plus recombinant interleukin 2 in patients with unresectable hepatocellular carcinoma

✍ Saburo Onishi; Toshiji Saibara; Masanao Fujikawa; Hiroshi Sakaeda; Yasushi Matsu 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 591 KB

Ten patients with hepatocellular carcinoma, three of whom had pulmonary metastasis, were treated with adoptive immunotherapy using autologous lymphokineactivated killer cells plus recombinant interleukin 2. Patients received 16 pg per day of recombinant interleukin 2 consecutively (for 14 to 64 days